- Filed
- Aug 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 5, 2024 | 2.71M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $4.59M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $7.57M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $8.78M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $9.92M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $11.29M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $5.15M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $3.93M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $10.45M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $1.28M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $2.09M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $4.72M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $8.02M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $10.07M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $13.37M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 2.28M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 2.23M sh |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$12.77M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$1.83 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$5.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$1.83 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$5.00 |
| Sga Expense restated | Q2 2024 · Jun 30, 2023 | $1.53M |
| Sga Expense restated | Q2 2024 · Jun 30, 2023 | $4.23M |
| Rd Expense restated | Q2 2024 · Jun 30, 2023 | $339K |
| Rd Expense restated | Q2 2024 · Jun 30, 2023 | $911K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$4.18M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$11.14M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$6.95M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | −$1.87M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | −$5.14M |